15 October 2014 - Deborah Wilkes
Archived
Johnson & Johnson's US OTC sales rose by just 1.0% to US$313 million in the third quarter of 2014, despite a significant increase for OTC analgesics.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.